ARCHIVES

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

This article is from The Cancer Letter archive.

Vol. 31 No. 8 | August 29, 2008

Download PDF Visit The Full Archive

Related Articles

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

March 10, 1989

Excitement building toward 2015 goal, NCI director says in FY07 bypass budget request. NCI seeks $5.8 billion.

December 2, 2005

CR Funds Agencies At FY08 Level Through March 6.

October 3, 2008

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014

RFAs In Bladder, Prostate, Ok’d By DCBDC Advisors

March 1, 1991

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

January 16, 2009